Kilitch Drugs Board Meeting for Q1 FY27 Results

Board Meeting Details

The Board of Directors meeting will be held on Thursday, 13 August 2026. The primary agenda is to consider and approve the unaudited Financial Results (both Standalone and Consolidated) of the Company for the quarter ended 30 June 2026 (Q1 FY27).

Trading Window Closure

Pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015 and subsequent amendments, including Circular No. LIST/COMP/01/2019-20 dated 24 April 2019 from BSE and Circular Reference no. NSE/CML/2019/11 dated 24 April 2019 from NSE, and in accordance with the Company's code of conduct for Prevention of Insider Trading, the Trading Window has been closed with effect from 1 July 2026. The Trading Window will re-open 48 hours after the financial results are disclosed to the Stock Exchanges.